Cassava Sciences | PTIE - Crediti Commerciali





Crediti Commerciali Cambiamento Data
Abbott USD 11.22B 655M 2026-03
Amgen USD 9.14B 432M 2026-03
Biogen USD 1.79B 76.6M 2026-03
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cassava Sciences USD 117K 3K 2026-03
Eisai JPY 227B 22.05B 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Geron USD 39.23M 1.57M 2025-12
J&J USD 22.54B 1.21B 2026-03
Merck USD 11.78B 345M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 16.17B 332M 2026-03
Roche Holding CHF 11.9B 460M 2025-12